These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15823280)

  • 21. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH.
    Huijgen R; Hutten BA; Kindt I; Vissers MN; Kastelein JJ
    Circ Cardiovasc Genet; 2012 Jun; 5(3):354-9. PubMed ID: 22553281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
    Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
    Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
    Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
    Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
    Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality.
    Versmissen J; Botden IP; Huijgen R; Oosterveer DM; Defesche JC; Heil TC; Muntz A; Langendonk JG; Schinkel AF; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2011 Dec; 219(2):690-3. PubMed ID: 21925660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia.
    Al-Rasadi K; Al-Waili K; Al-Zidi WA; Al-Abri AR; Al-Hinai AT; Al-Sabti HA; Al-Tobi S; Al-Zakwani I; Al-Zadjali F; Al-Hashmi K; Banerjee Y
    Angiology; 2014 Nov; 65(10):911-8. PubMed ID: 24249837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.
    Koivisto UM; Turtola H; Aalto-Setälä K; Top B; Frants RR; Kovanen PT; Syvänen AC; Kontula K
    J Clin Invest; 1992 Jul; 90(1):219-28. PubMed ID: 1634609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Children and Adolescents with Familial Hypercholesterolemia.
    Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M
    J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the single strand conformation polymorphism method for rapid screening for mutations in the low density lipoprotein receptor gene in patients with familial hypercholesterolemia: effect on plasma lipid levels of different classes of mutations.
    Gudnason V; Day IN; Humphries SE
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():6-8. PubMed ID: 8767444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern Greece.
    Miltiadous G; Elisaf M; Bairaktari H; Xenophontos SL; Manoli P; Cariolou MA
    Hum Mutat; 2001 May; 17(5):432-3. PubMed ID: 11317361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children.
    Wiegman A; Rodenburg J; de Jongh S; Defesche JC; Bakker HD; Kastelein JJ; Sijbrands EJ
    Circulation; 2003 Mar; 107(11):1473-8. PubMed ID: 12654602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia.
    Wiegman A; Sijbrands EJ; Rodenburg J; Defesche JC; de Jongh S; Bakker HD; Kastelein JJ
    Pediatr Res; 2003 Jun; 53(6):1008-12. PubMed ID: 12646733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.